VERAPAMIL HYDROCHLORIDE
- Product NDC
- 71610-405
- 11-digit product format
- 716100405
- Labeler code
- 71610
- Product ID
- 71610-405_335e56e6-a09f-488d-84dc-06f0b50950df
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VERAPAMIL HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA206173
- Marketing category
- ANDA
- Marketing start
- 2019-05-15
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V3888OEY5R | VERAPAMIL HYDROCHLORIDE | 152-11-4 | VERAPAMIL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-405-60 | 71610040560 | 90 TABLET in 1 BOTTLE (71610-405-60) | 90 tablet | 2020-03-18 | No | No | Historical |
| 71610-405-80 | 71610040580 | 180 TABLET in 1 BOTTLE (71610-405-80) | 180 tablet | 2020-03-18 | No | No | Historical |